Risk factors for in situ breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 12, 1996, Pages 961-965

  Longnecker, Matthew P ^a   Bernstein, Leslie ^b,c   Paganini Hill, Annlia ^b   Enger, Shelley M ^b   Ross, Ronald K ^b,c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; CALIFORNIA; CARCINOMA IN SITU; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; INTERVIEWS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029829552     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ernster, E. L., Barclay, J., Kerlikowske, K., Grady, D., and Henderson, C. Incidence of and treatment for ductal carcinoma in situ of the breasl. J. Am. Med. Assoc., 275: 913-918, 1996.
2. White, E., Lee, Y. L., and Kristal, A. R. Evaluation of the increase in breast cancer incidence in relation to mammography use. J. Natl. Cancer Inst., 82: 1546-1552, 1990.
3. Page, D. L., Steel, C. M., and Dixon, J. M. Carcinoma in situ and patients at high risk of breast cancer. Br. Med. J., 310: 39-42, 1995.
4. Millikan, R., Dressler, L., Geradts, J., and Graham, M. The need for epidemiologic studies of in situ carcinoma of the breast. Breast Cancer Res. Treat., 35: 65-77, 1995.
5. Brinton, L. A., Hoover, R., and Fraumeni, J. F., Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br. J. Cancer, 54: 825-832, 1986.
6. Schairer, C., Byrne, C., Keyl, P. M., Brinton, L. A., Sturgeon, S. R., and Hoover, R. N. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes & Control, 5: 491-500, 1994.
7. Brinton, L. A., Hoover, R., and Fraumeni, J. F., Jr. Epidemiology of minimal breast cancer. J. Am. Med. Assoc., 249: 483-487, 1983.
8. Bernstein, L., Hanisch, R., Sullivan-Halley, J., and Ross, R. K. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol., Biomarkers & Prev., 4: 437-440, 1995.
9. Longnecker, M. P., Paganini-Hill, A., and Ross, R. K. Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. Cancer Epidemiol., Biomarkers & Prev., 4: 721-725, 1995.
10. Bernstein, L., Henderson, B. E., Hanisch, R., Sullivan-Halley, J., and Ross, R. K. Physical exercise and reduced risk of breast cancer in young women. J. Natl. Cancer Inst., 86: 1403-1408, 1994.
11. Chu, J., Schweid, A. I., and Weiss, N. S. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. Am. J. Obstet. Gynecol., 143: 569-573, 1982.
12. Stanford, J. L., Weiss, N. S., Voigt, L. F., Daling, J. R., Habel, L. A., and Rossing, M. A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. Am. Med. Assoc., 274: 137-142, 1995.
13. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestins, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
14. Brinton, L. A., and Schairer, C. Estrogen replacement therapy and breast cancer risk. Epidemiol. Rev., 15: 66-79, 1993.
15. Stanford, J. L., and Thomas, D. B. Exogenous progestins and breast cancer. Epidemiol. Rev., 15: 98-107, 1993.
16. Brekelmans, C. T. M., Peeters, P. H. M., Faber, J. A. J., Deurenberg, J. J. M., and Collette, H. J. A. The epidemiological profile of women with an interval cancer in the DOM screening program. Breast Cancer Res. Treat., 30: 223-232, 1994.
17. Kelsey, J. L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15: 256-263, 1993.
18. Hsieh, C., Pavia, M., Lambe, M., Lan, S. J., Colditz, G. A., Ekbom, A., Adami, H. O., Trichopoulos, D., and Willett, W. C. Dual effect of parity on breast cancer risk. Eur. J. Cancer, 30A: 969-973, 1994.
19. Murphy, D. S., Hoare, S. F., Going, J. J., Mallon, E. E. A., George, W. D., Kaye, S. B., Brown, R., Black, D. M., and Keith, W. N. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J. Natl. Cancer Inst., 87: 1694-1704, 1995.
20. Aldaz, C. M., Chen, T., Sahin, A., Cunningham, J., and Bondy, M. Comparative allelotype of in situ and invasive human breast cancer high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res., 55: 3976-3981, 1995.
21. Page, D. L., and Jensen, R. A. Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. J. Am. Med. Assoc., 275: 948-949, 1996.
22. Derby, C. A., Hume, A. L., Barbour, M. M., McPhillips, J. B., Lasater, T. M., and Carleton, R. A. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am. J. Epidemiol., 137: 1125-1135, 1993.